|Articles|October 1, 2004
Questioning imiquimod's impact on scars
National report - Best known as the modern-day defender against basal cell carcinoma and actinic keratoses, imiquimod 5 percent cream (Aldara) is also gaining a reputation for its biosynthetic and clinical results in the treatment of scars - and evidence continues to mount supporting the immune response modifier's prominence in repealing one of the most notorious of scars: keloids.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
2
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
3
The Weekly Roundup: December 8-12
4
Transformative Advances This Year and Beyond
5














